Rockefeller Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-167
| Closed | -$8K | – | 2073 |
|
|
2022
Q4 | $8K | Buy |
167
+135
| +422% | +$6.47K | ﹤0.01% | 3157 |
|
|
2022
Q3 | $2K | Sell |
32
-35
| -52% | -$2.19K | ﹤0.01% | 3552 |
|
|
2022
Q2 | $3K | Sell |
67
-44
| -40% | -$1.97K | ﹤0.01% | 3618 |
|
|
2022
Q1 | $5K | Sell |
111
-161
| -59% | -$7.25K | ﹤0.01% | 3315 |
|
|
2021
Q4 | $12K | Buy |
272
+262
| +2,620% | +$11.6K | ﹤0.01% | 2871 |
|
|
2021
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 3683 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3428 |
|